# LOREEV XR
> **NDA214826** · New Drug Application · Sponsor: ALMATICA · Approved 2021-08-27
## Drug
- **FDA Application Number:** NDA214826
- **Application type:** New Drug Application
- **Brand name:** LOREEV XR
- **Generic name:** LORAZEPAM
- **Active ingredients:** LORAZEPAM
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALMATICA
- **Manufacturer:** Almatica Pharma LLC
- **First approval:** 2021-08-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214826)
---
*AI Analytics · CC0 1.0*